Beyond cancer, PLK2 and PLK3 have received attention in neurodegenerative diseases, because phosphorylation of synuclein at Ser129 is a hallmark of Parkinson disease and related synucleinopathies [96, 97]. This evidence concerns the gene PLK3 and synucleinopathy.